Prostate Cancer
📧 Sign up to get email alerts when something new happens for Prostate Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2020-04-08Clinical Trial Update: Deep Versus Moderate Neuromuscular Blockade During Laparoscopic Surgery [Phase 4]
Phase 4 trial comparing deep versus moderate neuromuscular blockade during laparoscopic surgery; results posted after completion.
-
CLINICAL_TRIALS trial_result · 2020-04-07Clinical Trial Update: North Carolina Prostate Cancer Comparative Effectiveness & Survivorship Study (NC ProCESS)
Clinical trial update for the NC ProCESS study in prostate cancer; completed with results posted in 2020.
-
CLINICAL_TRIALS trial_result · 2020-04-06Clinical Trial Update: ZD 1839 in Treating Patients With Prostate Cancer That Has Not Responded to Hormone Therapy [Phase 2]
Phase 2 trial update for ZD 1839 in hormone-refractory prostate cancer has completed.
-
CLINICAL_TRIALS trial_result · 2020-04-03Clinical Trial Update: Vitamin E, Selenium, and Soy Protein in Preventing Cancer in Patients With High-Grade Prostate Neoplasia [Phase 3]
Phase 3 trial evaluating vitamin E, selenium, and soy protein for prevention in men with high-grade prostate neoplasia has completed.
-
CLINICAL_TRIALS trial_result · 2020-04-03Clinical Trial Update: Hormone Therapy With or Without Surgery or Radiation Therapy in Treating Patients With Prostate Cancer [Phase 3]
Phase 3 trial evaluating hormone therapy with or without surgery or radiation in prostate cancer has completed.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2020-04-03Clinical Trial Update: Combination Chemotherapy in Treating Pain in Hormone Refractory Metastatic Prostate Cancer [Phase 3]
Phase 3 trial updating combination chemotherapy for pain in hormone-refractory metastatic prostate cancer; study completed.
-
CLINICAL_TRIALS trial_result · 2020-04-03Clinical Trial Update: Phase II Study of Sipuleucel-T and Indoximod for Patients With Refractory Metastatic Prostate Cancer [Phase 2]
Phase II study evaluating sipuleucel-T with indoximod for refractory metastatic prostate cancer has completed; results posted in 2020.
-
CLINICAL_TRIALS trial_result · 2020-03-30Clinical Trial Update: A Study of Docetaxel + ARN-509 in Castration-Resistant Prostate Cancer [Phase 2]
Phase 2 trial of docetaxel plus ARN-509 in castration-resistant prostate cancer was terminated; results posted.
-
CLINICAL_TRIALS trial_result · 2020-03-26Clinical Trial Update: Magnetic Resonance Imaging in Measuring the Effect of Cabozantinib in Patients With Castrate Resistant Prostate Cancer [Phase 2]
Phase 2 trial evaluating MRI as a measurement tool for the effect of cabozantinib in patients with castration-resistant prostate cancer.
-
CLINICAL_TRIALS trial_result · 2020-03-25Clinical Trial Update: Radical Retropubic Prostatectomy Versus Conventional External Beam Radiotherapy for Clinically Localized Prostate Cancer [Phase 3]
Phase 3 trial comparing radical retropubic prostatectomy to external beam radiotherapy for clinically localized prostate cancer; study curre…
-
CLINICAL_TRIALS trial_result · 2020-03-23Clinical Trial Update: MRI Guided Prostate Cancer Focal Laser Ablation [NA]
Clinical trial update for MRI-guided focal laser ablation in prostate cancer; study terminated with results posted.
-
FDA label_change · 2020-03-20FDA Approved: BICALUTAMIDE — Supplemental Application (Sun Pharmaceutical Industries, Inc.)
The FDA approved a supplemental application for Bicalutamide from Sun Pharmaceutical Industries, indicating a label update or related change…
-
CLINICAL_TRIALS trial_result · 2020-03-19Clinical Trial Update: Neoadjuvant Apalutamide (ARN509) and Radical Prostatectomy in Treatment of Intermediate to High Risk Prostate Cancer [Phase 2]
Phase 2 trial update evaluating neoadjuvant apalutamide with radical prostatectomy for intermediate to high-risk prostate cancer.
-
FDA approval · 2020-03-18FDA Approved: LUPRON DEPOT — Supplemental Application (AbbVie Inc.)
FDA approved a supplemental application for LUPRON DEPOT (leuprolide acetate) submitted by AbbVie Inc.
-
CLINICAL_TRIALS trial_result · 2020-03-18Clinical Trial Update: Trial of Abiraterone Acetate Plus LHRH-therapy Versus Abiraterone Acetate Sparing LHRH-therapy in Patients With Progressive Chemotherapy-naïve Castration-resistant Prostate Cancer (SPARE) [Phase 2]
Phase 2 trial SPARE comparing abiraterone acetate plus LHRH therapy versus abiraterone acetate with sparing LHRH therapy in chemotherapy-naï…
-
CLINICAL_TRIALS trial_result · 2020-03-16Clinical Trial Update: Effect of Neuromuscular Block and Arterial PCO2 on Surgical Rating Scale (SRS), Following Reversal With Sugammadex [NA]
A completed clinical trial evaluating the effect of neuromuscular block and arterial PCO2 on the Surgical Rating Scale after reversal with s…
-
CLINICAL_TRIALS trial_result · 2020-03-11Clinical Trial Update: The Role of Highly Selective Androgen Receptor (AR) Targeted Therapy in Men With Biochemically Relapsed Hormone Sensitive Prostate Cancer [Phase 2]
Phase 2 clinical trial update evaluating highly selective androgen receptor–targeted therapy in men with biochemically relapsed hormone-sens…
-
CLINICAL_TRIALS trial_result · 2020-03-03Clinical Trial Update: Green Tea Extract in Treating Patients With Low-Risk Prostate Cancer [Phase 2]
Phase 2 trial exploring green tea extract for Stage I and Stage II prostate cancer has been terminated; results posted in 2020.
-
CLINICAL_TRIALS trial_result · 2020-02-28Clinical Trial Update: PREvention of VENous ThromboEmbolism Following Radical Prostatectomy [Phase 4]
A Phase 4 clinical trial investigating prevention of venous thromboembolism after radical prostatectomy was terminated; results were posted …
-
CLINICAL_TRIALS trial_result · 2020-02-25Clinical Trial Update: Intraoperative Dosimetry for Prostate Brachytherapy Using Fluoroscopy and Ultrasound [NA]
A completed clinical trial evaluating intraoperative dosimetry for prostate brachytherapy using fluoroscopy and ultrasound; results posted i…
-
FDA approval · 2020-02-24FDA Approved: FIRMAGON — Supplemental Application (Ferring Pharmaceuticals Inc.)
The FDA approved a supplemental application for Firmagon (degarelix) from Ferring Pharmaceuticals Inc., resulting in an updated label for th…
-
CLINICAL_TRIALS trial_result · 2020-02-13Clinical Trial Update: Comparison of PET With [89Zr]-Df-IAb2M and [111In]-Capromab Pendetide in the Detection of Prostate Cancer Pre-Prostatectomy [Phase 2]
Phase 2 clinical trial comparing PET tracers [89Zr]-Df-IAb2M and [111In]-Capromab Pendetide for detecting prostate cancer before prostatecto…
-
CLINICAL_TRIALS trial_result · 2020-02-13Clinical Trial Update: Phase I/IIA Study of PET Imaging With 89Zr-Df-IAB2M in Metastatic Prostate Cancer [Phase 1, Phase 2]
A completed Phase 1/2A trial evaluating PET imaging with 89Zr-Df-IAB2M in metastatic prostate cancer.
-
CLINICAL_TRIALS trial_result · 2020-02-12Clinical Trial Update: Intra-operative Assessment of Cavernosal Nerve Stimulus Threshold [NA]
Clinical trial update on intra-operative assessment of cavernosal nerve stimulus threshold related to prostatectomy.
-
CLINICAL_TRIALS trial_result · 2020-02-10Clinical Trial Update: Study of the Effect of Chemotherapy With Cabazitaxel on Prostate Cancer [Phase 2]
Phase 2 trial evaluating chemotherapy with cabazitaxel in bone-metastatic prostate cancer has completed.